Physician profile
Jeffrey W Coco
NPI 1831127513
$508.92
in general payments reported to CMS, 2019-2025
5 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.06 · 2022: $63.73 · 2023: $138 · 2024: $138 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $429.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $263.61 | 2021-2025 | Dovato, Cabenuva, Apretude |
| Merck Sharp & Dohme LLC | $130.23 | 2023-2025 | Pifeltro, Delstrigo, Dificid |
| Theratechnologies INC. | $77.05 | 2022-2025 | Egrifta, Trogarzo |
| Exact Sciences Corporation | $25.31 | 2025 | The Cologuard Plus Collection Kit |
| Janssen Biotech, INC. | $12.72 | 2023 | Symtuza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Coco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.